GAMMA Investing’s MapLight Therapeutics MPLT Stock Holding History

GAMMA Investing’s Portfolio MPLT Stock Details MPLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.94K	Buy	190 +67	+54%	+$1.26K	﹤0.01%	3962
2026 Q2	$4.41K	Buy	123 +29	+31%	+$834	﹤0.01%	3522
2026 Q1	$1.91K	Buy	+94	New	+$1.68K	﹤0.01%	3679

Other funds holding MPLT

Market Street Wealth Management Advisors Indianapolis, Indiana $703M AUM 10.22% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

GAMMA Investing's MPLT Position: Q3 2026 in Review

GAMMA Investing increased its MapLight Therapeutics (MPLT) stake by 54% in Q3 2026, buying an estimated $1.26K and bringing the position to 190 shares worth $1.94K. The position accounts for ﹤0.01% of the portfolio, ranked #3962.

GAMMA Investing first reported a position in MPLT in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.41K in Q2 2026. 5 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.

GAMMA Investing held 190 shares of MapLight Therapeutics worth $1.94K as of Q3 2026.
GAMMA Investing bought 67 MapLight Therapeutics shares in Q3 2026, an estimated $1.26K.
MapLight Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #3962 holding.
GAMMA Investing first reported a position in MapLight Therapeutics in Q1 2026 and has held it in 3 quarters since.
GAMMA Investing's MapLight Therapeutics position peaked at $4.41K in Q2 2026.
5 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.